Article

Hemodynamic effects of calcium channel blockers at rest and during exercise in essential hypertension

The American Journal of Medicine (Impact Factor: 5.3). 11/1985; 79(4A):11-8. DOI: 10.1016/0002-9343(85)90495-4
Source: PubMed

ABSTRACT The main hemodynamic disturbance occurring in patients with essential hypertension is an increase in the total peripheral resistance. In young patients with hypertension, this disturbance is clearly seen during muscular exercise, even though the calculated resistance might be normal during rest. This article reports results of studies on the long-term hemodynamic effects of two calcium channel blockers, verapamil and nifedipine, in patients with mild to moderate hypertension. Twenty-five men, aged 20 to 64 years, with diastolic blood pressures between 100 and 120 mm Hg before treatment were studied at rest and during exercise on ergometer bicycles. Blood pressure was recorded intra-arterially, and cardiac output was measured. After this initial study, 10 patients were treated with verapamil (from 40 to 80 mg, three times daily) and 15 patients with nifedipine (long-acting form, from 40 to 80 mg daily). After one year, the hemodynamic study was repeated. Both drugs induced a reduction in blood pressure and in the total peripheral resistance without any reduction in the cardiac index. Verapamil reduced heart rate, particularly during exercise, but this effect was compensated by an increase in the stroke volume. The hemodynamic profile of these two calcium channel blockers clearly differs from the hemodynamic effects of beta blockers.

0 Followers
 · 
21 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The hemodynamic response to vasodilation induced by the new calcium channel antagonist nicardipine was studied in 10 patients with severe, chronic congestive heart failure. Rest and exercise hemodynamics were evaluated in the baseline state and after 1 week of oral nicardipine therapy (30 mg 3 times daily). In addition, respiratory gas exchange and arteriovenous oxygen difference were measured to assess changes in oxygen utilization. The responses of the sympathetic nervous system were evaluated by measuring plasma norepinephrine concentrations at rest and during maximal exercise. At rest, nicardipine administration was associated with significant reductions in mean systemic arterial pressure, systemic vascular resistance, pulmonary artery wedge pressure and pulmonary arterial pressure, and significant increases in cardiac index and stroke volume index. These effects were maintained during exercise. In contrast to findings with other calcium channel antagonists, no negative inotropic effect of nicardipine was identified. Nicardipine administration was associated with reduction of arteriovenous oxygen difference. Nicardipine had no effect on plasma norepinephrine concentrations, suggesting absence of reflex sympathetic nervous activation. Thus, nicardipine-mediated vasodilation leads to significant improvements in both rest and exercise cardiac performance.
    The American Journal of Cardiology 10/1986; 58(7):583-8. DOI:10.1016/0002-9149(86)90280-8 · 3.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: New antihypertensive agents with favorable hemodynamic and metabolic profiles have resulted in reappraisal of traditional step-care therapy using diuretics and beta blockers. Calcium channel blockers are among the new antihypertensive agents that offer better hemodynamic effect compared with beta blockers, and they do not have unwanted metabolic effects as do diuretics. Calcium channel blockers, such as nitrendipine, are effective as monotherapy and in combination with other antihypertensive agents, and are particularly useful in elderly, black and low-renin patients. Preliminary results from a multicenter, double-blind, randomized, parallel study comparing nitrendipine with propranolol in patients over 40 demonstrate similar blood pressure-lowering effectiveness; however, propranolol was associated with a higher incidence of side effects and study withdrawals. In a second study, addition of propranolol to nitrendipine monotherapy produced a further decrease in blood pressure that was sustained over the year of study. These data suggest that nitrendipine provides additional effective and safe antihypertensive therapy, which can be used in place of or in combination with beta blockers.
    The American Journal of Cardiology 10/1986; 58(8):8D-11D. DOI:10.1016/0002-9149(86)90416-9 · 3.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We evaluated the immediate hemodynamic response to nicardipine, administered as an intravenous bolus and 30-minute sustaining infusion, in 10 patients with systemic hypertension (HTN) and 10 patients with chronic congestive heart failure (CHF). Baseline systemic vascular resistance and the response to nicardipine for HTN (1968 +/- 657 to 905 +/- 256 dynes X sec X cm-5) and CHF (2002 +/- 988 to 1089 +/- 216 +/- 99 dynes X sec X cm-5) were virtually identical (P less than 0.01). In both groups there was a significant increase of cardiac index in response to afterload reduction: HTN, 2.70 +/- 0.46 to 4.47 +/- 1.01; CHF, 1.90 +/- 0.33 to 2.88 +/- 0.80 L/min/m2 (P less than 0.01), so that a negative inotropic effect was not evident. In HTN the increase in cardiac index was primarily the result of reflex increase of heart rate (67 +/- 16 to 95 +/- 25 bpm [P less than 0.05]), associated with norepinephrine increase from 402 +/- 243 to 744 +/- 364 pg/ml (P less than 0.001). In CHF the cardiac index increase was caused by a stroke volume index increase (23 +/- 4 to 33 +/- 9 ml/min; P less than 0.01), with no significant change in heart rate or norepinephrine. Thus nicardipine, by means of calcium channel antagonism, induced reversal of vasoconstriction. Differences in the cardiac response identify the importance of characterizing the pathophysiologic status of cardiac impairment to more accurately interpret pharmacologic interventions.
    Clinical Pharmacology &#38 Therapeutics 06/1987; 41(5):483-9. DOI:10.1038/clpt.1987.62 · 7.39 Impact Factor
Show more